Nike reports fiscal Q1 2027 results after Thursday’s close, and the stock has spent the week trading near a 12-year low. NKE was changing hands around $36.38 today, within a 52-week range that stretches from $35.22 all the way to $76.97. That upper bound is not a distant memory. It was the price just twelve months ago. The gap between those two numbers is the entire question entering October 1.
The stock has plunged to around 80% below its November 2021 peak, with strategic missteps and rising competition compounding the pressure. At roughly $54 billion in market capitalization, the P/E ratio sits at about 17 and the dividend yield has climbed to about 4.56%. That yield is part of the attraction. It is also part of the concern: in fiscal 2026, Nike paid about $2.4 billion in common dividends, versus about $2.2 billion in free cash flow.
When Nike reports after the close on October 1, the analyst consensus is looking for $0.44 in earnings per share on about $11.32 billion in revenue, representing expected year-over-year declines of roughly 11% and 3% respectively. That is the low bar. What matters more than whether Nike clears it is what CEO Elliott Hill says about the three things long-term investors actually need answered.
The Three Questions Thursday Has to Settle
First: is Nike Direct stabilizing? Fiscal 2026 revenue was flat at $46.4 billion, with gross margin rising 20 basis points to 42.9%. But that gross margin improvement happened against a backdrop where Nike Direct fell 9% in Q2 FY2026, driven by a 14% decline in Nike Digital, while wholesale increased 8%. The wholesale rebound is real. The digital channel deterioration has not stopped.
Second: what does China actually look like now? Greater China revenue fell 10% in fiscal Q3 2026. Bank of America’s recent field work found soft sports demand and limited consumer response to new products in the region. Nike’s China exposure is not a rounding error. It is a structural drag until proven otherwise.
Third: can margins hold under the new tariff schedule? With sales expected to remain weak, BofA sees Nike relying more on gross-margin gains and cost cuts, though lower tariffs could provide some relief, with current rates estimated at 10% to 12.5%, down from roughly 20% a year ago.
The Bear Case Just Got Louder
On September 25, Bank of America downgraded Nike to Underperform from Neutral, lowered its price target from $47 to $30, and projected negative sales growth through fiscal 2027, driven primarily by a disconnect between North American wholesale growth and sell-through rates. BofA warns that North American wholesale momentum is deteriorating as retail sell-through fails to keep pace with inventory shipments, particularly for legacy product lines.
The competitors circling are not slowing down. Kylian Mbappé parted ways with Nike in September and signed with On, a brand that has captured meaningful share in the performance running category that Nike once owned outright. Deckers, On Holding, and Birkenstock were all hitting 52-week lows in mid-September, suggesting sector-wide pressure, but Nike’s decline runs deeper than the cycle.
What the Long-Term Investor Needs to See
Hill’s turnaround plan, branded internally as “Win Now,” rests on five pillars: culture, product, marketing, marketplace, and in-person experiences. The biggest shift is rebuilding wholesale partnerships after the prior CEO’s direct-to-consumer push failed. Wholesale revenue rose 8% to $7.5 billion in Q2 FY2026. That is progress. But wholesale growth that outruns actual sell-through is not durable, as BofA’s field checks suggest.
Morningstar’s wide-moat rating rests on Nike’s intangible brand asset, with analysts believing it will maintain premium pricing and generate economic profits for at least 20 years. With global visibility through sports sponsorships, Nike remains the largest athletic footwear brand in most markets. That brand does not disappear at $36. But brands erode faster than balance sheets when product relevance slips.
Thursday’s call is not a moment to decide Nike is fixed. It is a moment to assess whether the evidence for fixing is compounding or stalling. Direct sales trajectory, China stabilization, and gross margin guidance under the current tariff schedule are the three signals worth watching. If all three move in the right direction, the stock at 12-year lows begins to look like the opportunity the price implies. If even one deteriorates, the patience required grows considerably longer.
